{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:15:36Z","timestamp":1775830536327,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671553"],"award-info":[{"award-number":["81671553"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["2017-338"],"award-info":[{"award-number":["2017-338"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010120","name":"Huashan Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010120","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.cyto.2021.155642","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T04:57:47Z","timestamp":1627275467000},"page":"155642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset Still\u2019s disease: A prospective cohort study"],"prefix":"10.1016","volume":"146","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haocheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingluan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cyto.2021.155642_b0005","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.amjmed.2010.03.021","article-title":"The clinical and prognostic importance of positive blood cultures in adults","volume":"123","author":"Pien","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cyto.2021.155642_b0010","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1038\/emi.2016.22","article-title":"Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies","volume":"5","author":"Zhang","year":"2016","journal-title":"Emerg. Microbes Infect."},{"issue":"6","key":"10.1016\/j.cyto.2021.155642_b0015","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1017\/S0950268806007631","article-title":"Burden of community-onset bloodstream infection: a population-based assessment","volume":"135","author":"Laupland","year":"2007","journal-title":"Epidemiol. Infect."},{"issue":"3","key":"10.1016\/j.cyto.2021.155642_b0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00003495-200868030-00005","article-title":"Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances","volume":"68","author":"Kontzias","year":"2008","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.cyto.2021.155642_b0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients","volume":"93","author":"Gerfaud-Valentin","year":"2014","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.cyto.2021.155642_b0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10067-002-0680-3","article-title":"Fever of unknown origin: a review of 20 patients with adult-onset Still's disease","volume":"22","author":"Mert","year":"2003","journal-title":"Clin. Rheumatol."},{"issue":"11","key":"10.1016\/j.cyto.2021.155642_b0035","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3899\/jrheum.100247","article-title":"Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis","volume":"37","author":"Rau","year":"2010","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155642_b0040","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3899\/jrheum.130575","article-title":"Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis","volume":"41","author":"Priori","year":"2014","journal-title":"J. Rheumatol."},{"issue":"6227","key":"10.1016\/j.cyto.2021.155642_b0045","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.aaa4268","article-title":"Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis","volume":"347","author":"Weber","year":"2015","journal-title":"Science (New York, NY)"},{"issue":"2","key":"10.1016\/j.cyto.2021.155642_b0050","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/cc5783","article-title":"Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis","volume":"11","author":"Bozza","year":"2007","journal-title":"Critical Care (London, England)"},{"key":"10.1016\/j.cyto.2021.155642_b0055","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13075-015-0773-4","article-title":"Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease","volume":"17","author":"Han","year":"2015","journal-title":"Arthritis Res. Therapy"},{"issue":"5","key":"10.1016\/j.cyto.2021.155642_b0060","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10067-012-1952-1","article-title":"Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome","volume":"31","author":"Kasama","year":"2012","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155642_b0065","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155642_b0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.cyto.2021.155642_b0075","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1128\/IAI.68.7.3965-3970.2000","article-title":"Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model","volume":"68","author":"Wang","year":"2000","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.cyto.2021.155642_b0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/109629603766956960","article-title":"Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients","volume":"4","author":"Heagy","year":"2003","journal-title":"Surgical Infect."},{"issue":"3","key":"10.1016\/j.cyto.2021.155642_b0085","first-page":"217","article-title":"Whole blood pro-inflammatory cytokines and adhesion molecules post-lipopolysaccharides exposure in hyperbaric conditions","volume":"15","author":"Fildissis","year":"2004","journal-title":"Eur. Cytokine Netw."},{"issue":"1","key":"10.1016\/j.cyto.2021.155642_b0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/jir.2008.0015","article-title":"Bovine colostrum modulates cytokine production in human peripheral blood mononuclear cells stimulated with lipopolysaccharide and phytohemagglutinin","volume":"29","author":"Shing","year":"2009","journal-title":"J. Interferon Cytokine Res. : Off. J. Int. Soc. Interferon Cytokine Res."},{"issue":"9","key":"10.1016\/j.cyto.2021.155642_b0095","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s10096-018-3292-9","article-title":"Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007\u20132015)","volume":"37","author":"De Angelis","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis. : Off. Publ. Eur. Soc. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.cyto.2021.155642_b0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cmi.2017.07.032","article-title":"Utility of prior cultures in predicting antibiotic resistance of bloodstream infections due to Gram-negative pathogens: a multicentre observational cohort study","volume":"24","author":"MacFadden","year":"2018","journal-title":"Clin. Microbiol. Infect. : Off. Publ. Eur. Soc. Clinical Microbiol. Infect. Dis."},{"key":"10.1016\/j.cyto.2021.155642_b0105","first-page":"8763135","article-title":"Evaluating the Trends of Bloodstream Infections among Pediatric and Adult Patients at a Teaching Hospital of Kathmandu, Nepal: Role of Drug Resistant Pathogens","volume":"2017","author":"Parajuli","year":"2017","journal-title":"Can. J. Infect. Dis. Medical Microbiol. = J. Can. Maladies Infectieuses et de la Microbiologie Medicale"},{"issue":"10","key":"10.1016\/j.cyto.2021.155642_b0110","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S1473-3099(17)30394-8","article-title":"Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998\u20132016): a surveillance study","volume":"17","author":"Musicha","year":"2017","journal-title":"Lancet. Infect. Dis"},{"issue":"16","key":"10.1016\/j.cyto.2021.155642_b0115","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"New Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cyto.2021.155642_b0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1469-0691.2010.03262.x","article-title":"Trends among pathogens reported as causing bacteraemia in England, 2004\u20132008","volume":"17","author":"Wilson","year":"2011","journal-title":"Clin. Microbiol. Infect. : Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"issue":"7","key":"10.1016\/j.cyto.2021.155642_b0125","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.cyto.2021.155642_b0130","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.idc.2017.07.010","article-title":"Sepsis in Older Adults","volume":"31","author":"Rowe","year":"2017","journal-title":"Infect. Dis. Clin. North Am."},{"issue":"2","key":"10.1016\/j.cyto.2021.155642_b0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/SHK.0000000000000182","article-title":"Age-related differences in biomarkers of acute inflammation during hospitalization for sepsis","volume":"42","author":"Ginde","year":"2014","journal-title":"Shock (Augusta, Ga)"},{"key":"10.1016\/j.cyto.2021.155642_b0140","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.3389\/fimmu.2018.03099","article-title":"Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis","volume":"9","author":"Hu","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155642_b0145","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3904\/kjim.2016.068","article-title":"Red blood cell distribution width is useful in discriminating adult onset Still's disease and sepsis within 24 hours after hospitalization","volume":"33","author":"Park","year":"2018","journal-title":"Korean J. Internal Med."},{"issue":"3","key":"10.1016\/j.cyto.2021.155642_b0150","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3349\/ymj.2014.55.3.753","article-title":"Delta neutrophil index as an early marker for differential diagnosis of adult-onset Still's disease and sepsis","volume":"55","author":"Park","year":"2014","journal-title":"Yonsei Med. J."},{"issue":"3","key":"10.1016\/j.cyto.2021.155642_b0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.blre.2008.08.001","article-title":"Ferritin for the clinician","volume":"23","author":"Knovich","year":"2009","journal-title":"Blood Rev."},{"key":"10.1016\/j.cyto.2021.155642_b0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Ros\u00e1rio","year":"2013","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.cyto.2021.155642_b0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s13317-010-0009-1","article-title":"Adult-onset Still disease: a rare disorder with a potentially fatal outcome","volume":"1","author":"Priori","year":"2010","journal-title":"Auto- Immunity Highlights"},{"issue":"4","key":"10.1016\/j.cyto.2021.155642_b0170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/s10165-008-0065-9","article-title":"Successful treatment with plasma exchange in adult-onset Still's disease with hyper-IL-18-naemia and hyperallergic state","volume":"18","author":"Ito","year":"2008","journal-title":"Mod. Rheumatol."},{"issue":"10","key":"10.1016\/j.cyto.2021.155642_b0175","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00134-002-1410-7","article-title":"Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial","volume":"28","author":"Busund","year":"2002","journal-title":"Intensive Care Med."},{"issue":"9","key":"10.1016\/j.cyto.2021.155642_b0180","first-page":"1425","article-title":"Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome","volume":"19","author":"Coffernils","year":"1992","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.cyto.2021.155642_b0185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.autrev.2007.01.016","article-title":"Ferritin in autoimmune diseases","volume":"6","author":"Zandman-Goddard","year":"2007","journal-title":"Autoimmun. Rev."},{"issue":"8532","key":"10.1016\/j.cyto.2021.155642_b0190","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0140-6736(87)90204-2","article-title":"Increased serum ferritin levels in adult Still's disease","volume":"1","author":"Ota","year":"1987","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.cyto.2021.155642_b0195","first-page":"322","article-title":"Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease","volume":"28","author":"Fautrel","year":"2001","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.cyto.2021.155642_b0200","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.smim.2013.10.014","article-title":"Interleukin-18, more than a Th1 cytokine","volume":"25","author":"Novick","year":"2013","journal-title":"Semin. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155642_b0205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/77811","article-title":"IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6","volume":"1","author":"Yoshimoto","year":"2000","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2021.155642_b0210","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.4049\/jimmunol.162.9.5070","article-title":"IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response","volume":"162","author":"Hoshino","year":"1999","journal-title":"J. Immunol. (Baltimore, Md : 1950)"},{"key":"10.1016\/j.cyto.2021.155642_b0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","article-title":"Interleukin-18 and IL-18 binding protein","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2021.155642_b0220","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1164\/rccm.201903-0659OC","article-title":"Synergistic Signaling of TLR and IFN\u03b1\/\u03b2 Facilitates Escape of IL-18 Expression from Endotoxin Tolerance","volume":"201","author":"Verweyen","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.cyto.2021.155642_b0225","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: Biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.cyto.2021.155642_b0230","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00024382-200210000-00002","article-title":"Differential regulation of systemic IL-18 and IL-12 release during postoperative sepsis: high serum IL-18 as an early predictive indicator of lethal outcome","volume":"18","author":"Emmanuilidis","year":"2002","journal-title":"Shock (Augusta, Ga)"},{"issue":"3","key":"10.1016\/j.cyto.2021.155642_b0235","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1164\/rccm.201308-1535OC","article-title":"Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock","volume":"189","author":"Vanden Berghe","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.cyto.2021.155642_b0240","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/gerona\/63.8.879","article-title":"ELISA and multiplex technologies for cytokine measurement in inflammation and aging research","volume":"63","author":"Leng","year":"2008","journal-title":"J. Gerontol. Series A, Biol. Sci. Med. Sci."},{"issue":"7\u20138","key":"10.1016\/j.cyto.2021.155642_b0245","first-page":"447","article-title":"Procalcitonin's role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator?","volume":"75","author":"Dahaba","year":"2009","journal-title":"Minerva Anestesiol."},{"issue":"9","key":"10.1016\/j.cyto.2021.155642_b0255","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.4049\/jimmunol.164.9.4783","article-title":"Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis","volume":"164","author":"Schwarzenberger","year":"2000","journal-title":"J. Immunol. (Baltimore, Md : 1950)"},{"key":"10.1016\/j.cyto.2021.155642_b0260","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s13054-015-1125-0","article-title":"Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients","volume":"19","author":"Hoogendijk","year":"2015","journal-title":"Critical Care (London, England)"},{"issue":"3","key":"10.1016\/j.cyto.2021.155642_b0265","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/cc13902","article-title":"The role of CXCL10 in the pathogenesis of experimental septic shock","volume":"18","author":"Herzig","year":"2014","journal-title":"Critical Care (London, England)"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:03:45Z","timestamp":1760907825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621002283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":52,"alternative-id":["S1043466621002283"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155642","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset Still\u2019s disease: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"155642"}}